IL17A and metabolic dysfunction-associated steatohepatitis: However, increased levels of Th17 cells and their cytokines are found in blood and livers of patients with chronic liver diseases [56–58], and recombinant IL-17A administration induces non-alcoholic steatohepatitis (NASH) in mice [57].